House Oversight and Reform Committee Hearing on Drug Prices with CEO's

House Oversight and Reform Committee Hearing on Drug Prices with CEO's

Dr. Giovanni Caforio, CEO of Bristol Myers Squibb, Kåre Schultz, CEO of Teva Pharmaceuticals, and Mark Alles, former CEO of Celgene Corporation, are remotely sworn in during a hearing before the House Committee on Oversight and Reform Committee hearing to discuss unsustainable drug prices with CEO's of major drug companies on Capitol Hill in Washington, DC on Wednesday, September 30, 2020. Pool Photo by Greg Nash/UPI